Research Article

The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis

Table 1

Baseline demographic, clinical, and laboratory characteristics of the study patients according to tertiles of AST/ALT (De-Ritis ratio).

1 st tertile ()2 st tertile ()3 st tertile () value

De Ritis ratio0.68 (0.50-0.85)1.34 (1.17-1.58)2.89 (2.28-3.96)<0.001
ALT, U/L90.9 (52.0-193.2)67.9 (37.3-147.9)46.2 (26.9-98.4)<0.001
AST, U/L55.9 (32.2-125.9)96.4 (49.6-196.6)140.0 (81.40-288.0)<0.001
Male, (%)58 (59.8)65 (68.4)56 (57.7)0.271
Age, years49 (37-64)55 (43-66)58 (42-65)0.074
ANC, 109/L1.13 (0.82-2.73)0.98 (0.69-1.92)0.89 (0.69-2.32)0.132
HB, g/L89 (74-103)85 (69-104)83 (70-94)0.277
PLT, 109/L61 (35-90)41 (24-61)36 (20-60)<0.001
LDH, U/L452 (336-660)676 (382-1025)1195 (683-1990)<0.001
ALB, g/L27.60 (5.01)27.02 (5.47)26.87 (4.59)0.568
TG, mmol/L2.36 (1.60-3.57)2.35 (1.63-3.27)2.86 (2.00-4.43)0.002
FIB, g/L1.66 (1.11-2.32)1.44 (0.91-2.12)1.46 (1.05-2.18)0.466
Ferritin, ug/L3137 (1321-8024)5043 (2193-14576)6258 (1600-17400)0.016
sCD25, ng/L31212 (17540-43915)34687 (16915-51866)37622 (17744-54064)0.607
Splenomegaly (%)85 (87.6)82 (86.3)89 (91.8)0.465
Hepatomegaly (%)15 (15.5)21 (22.1)16 (16.5)0.437
Lymphadenopathy (%)42 (43.3)56 (58.9)53 (54.6)0.08
Hemophagocytic (%)91 (93.8)86 (90.5)80 (82.5)0.035
HScore, points224 (196-258)239 (207-269)244 (220-274)0.011
EBV infection (%)45 (46.4)56 (58.9)45 (46.4)0.134
Etiology0.053
 MHLH (%)46 (47.4)57 (60.0)62 (63.9)
 Non-MHLH (%)51 (52.6)38 (40.0)35 (36.1)
Chemotherapy (%)86 (88.7)88 (92.6)84 (86.6)0.39

Abbreviations: ALT: alanine transaminase; AST: aspartate transaminase; De-Ritis ratio: aspartate transaminase/alanine transaminase; ANC: absolute neutrophil count; HB: hemoglobin; PLT: platelet; LDH: lactate dehydrogenase; ALB: albumin; TG: triglyceride; FIB: fibrinogen; sCD25: soluble interleukin-2 receptor; β2-MG: beta2-microglobulin; EBV: Epstein-Barr virus; MHLH: malignancy-associated hemophagocytic lymphohistiocytosis; Non-MHLH: nonmalignancy associated hemophagocytic lymphohistiocytosis.